MetaCap

Who Owns Immuneering Stock?

NASDAQ: IMRXHealth CareBiotechnology: Pharmaceutical PreparationsUSD

3.38-0.07 (-2.03%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Ownership breakdown

Held by institutions
58.04%
Institutional holders
163
  • Institutions 58.0%
  • Insiders 14.2%
  • Public and other 27.7%

Who owns Immuneering stock?

Institutional investors own about 58.0% of Immuneering's shares, spread across 163 institutions that file 13F reports. That level of institutional ownership is moderate. Insiders, including executives, directors and large founding shareholders, hold 14.24% of IMRX.

The largest institutional holders are FMR, LLC (14.20%), Blackrock Inc. (6.75%) and Sanofi (4.18%). Together, the top 10 institutions control 39.4% of shares outstanding. In their latest filings, 7 of the top 10 institutions increased their IMRX positions and 2 reduced them.

Summary generated from market data by MetaCap's automated system. Methodology

Top institutional holders of IMRX

Immuneering top institutional holders
InstitutionShares% HeldChange
FMR, LLC9.19M14.20%-5.3%
Blackrock Inc.4.37M6.75%+190.2%
Sanofi2.71M4.18%0.0%
Vanguard Capital Management LLC2.29M3.53%-0.1%
Price (T.Rowe) Associates Inc1.94M2.99%+5.8%
Geode Capital Management, LLC1.37M2.12%+0.3%
State Street Corporation1.15M1.78%+15.0%
Nuveen, LLC869.39K1.34%+98.3%
DCF Advisers, LLC862.50K1.33%+9.2%
Aberdeen Group plc784.95K1.21%+100.0%

% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.

Top mutual fund and ETF holders of IMRX

Immuneering top fund holders
FundShares% Held
Fidelity Mt. Vernon Street Trust-Fidelity Growth Company Fund2.93M4.53%
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund1.62M2.51%
iShares Trust-iShares Russell 2000 ETF1.42M2.20%
Fidelity Select Portfolios-Select Biotechnology Portfolio1.10M1.69%
T. Rowe Price New Horizons Fund, Inc.906.76K1.40%
Fidelity Mt. Vernon Street Trust-Fidelity Series Growth Company Fund681.21K1.05%
VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund612.34K0.95%
Fidelity Salem Street Trust-Fidelity Small Cap Index Fund594.40K0.92%
iShares Trust-iShares Russell 2000 Value ETF530.88K0.82%
iShares Trust-iShares Biotechnology ETF449.08K0.69%

Frequently asked questions

Who is the largest shareholder of Immuneering?

FMR, LLC is the largest institutional shareholder of IMRX, owning 14.20% of shares outstanding (9.19M shares) as of its latest 13F filing.

What percentage of Immuneering is owned by institutions?

Institutions own about 58.0% of IMRX shares and 67.7% of the public float.

How much of Immuneering do insiders own?

Insiders, such as officers and directors, own about 14.24% of IMRX shares outstanding.

Where does institutional ownership data come from?

Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.

Related